We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Resmed Inc | ASX:RMD | Australian Stock Exchange | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.04 | -0.12% | 32.96 | 32.90 | 33.00 | 33.27 | 32.84 | 33.08 | 2,135,770 | 07:20:01 |
From May 2019 to May 2024
At ResMed we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
Company:
ResMed
Headquarters Address:
9001 Spectrum Center Blvd
San Diego, CA 92123
Main Telephone:
858.836.5000
Website:
www.resmed.com
Ticker:
(NYSE: RMD)
(ASX: RMD)
Type of Organization:
Public
Industry:
Medical Devices
Earnings Release Dates:
2nd Quarter: January 30, 2020
3rd Quarter: April 30, 2020
Key Executives:
CEO: Mick Farrell
President and COO: Rob Douglas
Public Relations
Contact:
Jayme Rubenstein
Phone:
858.836.6798
Email:
news@resmed.com
Investor Relations
Contact:
Amy Wakeham
Phone:
858.836.5000
Email:
investorrelations@resmed.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200501005541/en/
1 Year Resmed Chart |
1 Month Resmed Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
